Ryan Terry-Lorenzo

Ryan Terry-Lorenzo is currently the Director of Translational Science at Neurocrine Biosciences. Prior to this role, Ryan held various positions at companies such as Sunovion Pharmaceuticals, Myrexis, and Myriad Pharmaceuticals, as well as postdoctoral fellow positions at Stanford University and Duke University. With a Ph.D. in Pharmacology from Duke University and a B.A. in Biology from Wittenberg University, Ryan has extensive experience in leading projects related to central nervous system function and drug discovery, particularly in the area of schizophrenia and neuroimaging technologies.